The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The DNA And Gene Chip Market By The End Of 2030?
The dna and gene chip market has seen considerable growth in recent times. Its value is expected to rise from $9.2 billion in 2025 to $10.45 billion in 2026, showing a compound annual growth rate (CAGR) of 13.6%. This historical expansion can be attributed to several factors including an increase in genomic research activities, the growing adoption of molecular diagnostics, the development of cancer research programs, the greater availability of advanced microarray platforms, and an expansion of academic genomics funding.
The dna and gene chip market is projected to experience substantial expansion in the coming years, reaching $16.99 billion by 2030, with a compound annual growth rate (CAGR) of 12.9%. This anticipated growth is driven by several factors, including a heightened emphasis on personalized medicine, increased investment in genomics-based drug discovery, the broadening of population-scale genetic screening, the rising integration of AI-driven genomic analytics, and the expanded application of gene chips within agrigenomics. Key trends during this period are expected to encompass the wider adoption of high-density gene expression arrays, the increasing utilization of single-cell analysis chips, an escalating demand for precision oncology diagnostics, the broader deployment of SNP and whole genome analysis chips, and a greater emphasis on high-throughput genomic screening.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp
Which Market Drivers Are Supporting The Expansion Of The DNA And Gene Chip Market?
The increasing need for detecting cancer early is a major factor boosting the expansion of the DNA and gene market. Cancer encompasses a wide range of illnesses that can arise in virtually any bodily organ or tissue when abnormal cells proliferate without control, breach typical cell limits to infiltrate adjacent organs, and metastasize to other body parts. This heightened demand for early cancer identification is driven by increasing public awareness regarding the advantages of discovering cancer in its initial phases, prompting individuals to pursue timely screenings, thereby enhancing treatment results and survival prospects. DNA and gene chips serve to assess gene expression profiles, delineate the genetic and epigenetic makeup, and quantify genomic regulatory elements that are bound by cancer transcription factors within malignant cells. For example, as reported in May 2025 by the National Cancer Institute (NCI), a federal government agency based in the US, projections for 2025 indicate that the United States is anticipated to experience approximately 2,041,910 new cancer diagnoses and around 618,120 fatalities due to the illness. Consequently, the escalating need for early cancer identification is propelling the expansion of the DNA and gene chip market.
Which Segment Classifications Shape The DNA And Gene Chip Market?
The dna and gene chip market covered in this report is segmented –
1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA)
2) By Application: Cancer Diagnostics, Gene Expression, Genomics, Drug Discovery, Agrigenomics
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users
Subsegments:
1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays
2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays
How Are Trends Impacting The DNA And Gene Chip Market?
Leading companies within the DNA and gene chip market are creating innovative genotyping chips, such as Axiom YNS_Mol1, to drive progress in the food sector and promote the widespread adoption of insect consumption. Axiom YNS_Mol1 functions as a genotyping chip specifically engineered for insect breeding, particularly for the Tenebrio Molitor mealworm. For instance, in June 2023, Ÿnsect, a company based in France known for insect production, introduced Axiom YNS_Mol1, which is the World’s first genotyping chip for insect breeding. This groundbreaking genotyping chip was developed in collaboration with Thermo Fisher Scientific, with the aim of transforming insect breeding for sustainable food and pet food sources. It works by analyzing genetic traits, thereby fostering genomic diversity and enhancing characteristics like growth, reproduction, and resistance to diseases in Tenebrio Molitor mealworms. This pioneering initiative forms part of Ÿnsect’s ŸnFABRE project, contributing to the development of entomoculture and offering sustainable solutions to address environmental issues.
Which Companies Are Expanding Their Footprint In The DNA And Gene Chip Market?
Major companies operating in the dna and gene chip market are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., CapitalBio Corporation, Microarrays Inc., Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Fluidigm Corporation, LC Sciences, Macrogen Inc., Greiner Bio-One International GmbH, F. Hoffmann-La Roche Ltd, GE Healthcare, Hitachi High-Technologies Corporation
Read the full dna and gene chip market report here:
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report
How Is The DNA And Gene Chip Market Distributed Across Key Geographic Regions?
North America was the largest region in the DNA and gene chip market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene chip market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored DNA And Gene Chip Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8205&type=smp
Browse Through More Reports Similar to the Global DNA And Gene Chip Market 2026, By The Business Research Company
Consumer Genomics Market Report 2026
https://www.thebusinessresearchcompany.com/report/consumer-genomics-global-market-report
Recombinant Dna Technology Market Report 2026
https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report
Plasmid Dna Manufacturing Market Report 2026
https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model